April Newsmakers

TRADES, INDUSTRY, INSTITUTIONS, NONPROFITS, GOVT (continued)

Behind the FDA Approval: Omidubicel for Blood Cancers in Need of HSCT (Targeted Oncology)
Features Mitchell Horwitz, MD

WATCH: Dr Horwitz on the FDA Approval of Omidubicel in Blood Cancers Requiring Transplant (OncLive)
Features Mitchell Horwitz, MD

“A New Approach to Identifying Patients Who May Benefit from PSMA-Targeted Therapy” (Prostate Cancer Foundation)
Features Andrew Armstrong, MD, MHSc

WATCH: PSMA-Targeted Radioligand Therapy and Liquid Biopsy Characterizing PSMA Expression in Men with Metastatic Castration-Resistant Prostate Cancer - Andrew Armstrong (UroToday)
Features Andrew Armstrong, MD, MHSc

Deborah Kaye, MD, on the Cost of First-Line Tx for Metastatic Castrate-resistant Prostate Cancer (MedPage Today)
Features Deborah Kaye, MD

Elacestrant: This breast cancer treatment had a 30-year journey to FDA approval (MD Linx)
Features Suzanne Wardell, PhD

Radical nephroureterectomy vs. nephron sparing surgery in upper tract urothelial carcinoma (Medpage Today)
Features John Dudinec (medical student)

Childhood cancer survivors maintaining a healthy lifestyle may have lower risk of mortality (News Medical Life Sciences)
Features Kevin Oeffinger, MD

MSK researchers want to test new chemo delivery method to bypass toxicity in DPD-deficient patients (Precision Oncology News) 
Features Michael Lidsky, MD

761 exceptional women in oncology, per Castle Connolly (Becker’s Hospital Review) 
Features Kathleen Cooney, MD; Susan Kreissman, MD; Linda Marie Sutton, MD; Kimberly Blackwell, MD; Melanie Thomas; Jennifer Garst, MD; Angeles Alvarez Secord, MD, MHSc; Laura Havrilesky, MD

CV risk factor disparities in childhood cancer survivors similar to general population (Healio Cardiology)
Features David Noyd, MD

Early supportive care extends life, eases cancer symptoms (Cure Today)
Features Arif Kamal, MD

Top 15 research medical schools, per US News’ updated methodology (Becker’s Hospital Review)
Duke University (9)

Uterine cancer mortality on the rise, but research remains underfunded (Endocrinology Adviser)
Features Linda Zambrano Guevera, MD candidate

Clinical trial participation may be associated with improved overall survival in patients with ovarian cancer (ASCO Post)
Features Linda Zambrano Guevera, MD

Uterine cancer mortality on the rise, but research remains underfunded (Cancer Therapy Advisor)
Features Linda Zambrano Guevera, MD

Video Roundtable Series: HER2-Positive Metastatic Colorectal Cancer (the ASCO Post)
Features John Strickler, MD

Extravascular Hemolysis and Residual Anemia in Paroxysmal Nocturnal Hemoglobinuria
Features Carlos M. de Castro III, MD

Therapy for Small, HER2-Positive Breast Tumors Is Highly Effective After 10 Years (Cancer Health) 
Features Paul Kelly Marcom, MD

Healthy lifestyle associated with reduced mortality risk in childhood cancer survivors (St. Jude’s Children’s Research Hospital)
Features Kevin Oeffinger, MD

WATCH: "From Bench to Bedside to Curbside and Back: Addressing Rare Cancer Health Disparities focusing on IBC" (Association for Clinical and Translational Science Annual Meeting)
Features Gayathri Devi, PhD

LISTEN: Brain Tumor Survivor Sandra Hillburn on the Treatment that Saved Her Life (Cancer History Project/Cancer Letter)
Features John Sampson, MD, PhD; Henry Friedman, MD; and Allan Friedman, MD; and patient Sandra Hillburn

Rapid Advances Shake Up Treatment Considerations in ALL, CML, AML (OncLive)
Features Harry Erba, MD, PhD

Patient Profile: A 35-Year-Old Woman with Chronic GVHD (Targeted Oncology)
Features Nelson Chao, MD, MBA

WATCH: Navigating Goals-of-Care Conversations in Gynecologic Oncology (Consultant 360/SGO)
Features Brittany Davidson, MD, at the SGO Meeting

WATCH: Angelo Moore, PhD, RN, NE-BC, Discusses the Importance of Communication at the "A Better Wake DEI Blueprint Town Hall" (Raleigh Chamber of Commerce Twitter)